HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Roest Selected Research

Kallikreins (Kallikrein)

1/2022Kallikrein augments the anticoagulant function of the protein C system in thrombin generation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Roest Research Topics

Disease

17Thrombosis (Thrombus)
02/2024 - 07/2002
8Hemorrhage
02/2024 - 03/2014
7Cardiovascular Diseases (Cardiovascular Disease)
02/2024 - 02/2005
5Neoplasms (Cancer)
02/2024 - 01/2018
5Inflammation (Inflammations)
01/2022 - 03/2005
5Stroke (Strokes)
01/2022 - 12/2003
5Sepsis (Septicemia)
01/2020 - 01/2017
5Myocardial Infarction
03/2015 - 04/2006
5Breast Neoplasms (Breast Cancer)
12/2005 - 11/2003
4Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
06/2006 - 02/2005
3Malaria
01/2022 - 12/2010
3Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
12/2021 - 12/2004
3Thrombocytopenia (Thrombopenia)
12/2021 - 08/2013
3Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
09/2017 - 04/2014
3Pre-Eclampsia (Preeclampsia)
02/2016 - 04/2008
3Ischemic Stroke
03/2015 - 08/2005
3Coronary Disease (Coronary Heart Disease)
08/2011 - 04/2006
2Hypertension (High Blood Pressure)
02/2024 - 11/2009
2Fibrosis (Cirrhosis)
10/2023 - 01/2020
2Critical Illness (Critically Ill)
12/2022 - 01/2020
2Venous Thrombosis (Deep-Vein Thrombosis)
01/2022 - 07/2002
2Convalescence
01/2022 - 01/2020
2Infections
01/2022 - 01/2017
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
12/2021 - 03/2014
2HELLP Syndrome
12/2021 - 04/2008
2Hemolysis
12/2021 - 04/2008
2Vascular Diseases (Vascular Disease)
05/2015 - 08/2005
2Thrombotic Microangiopathies
01/2015 - 03/2014
2Hemophilia A (Haemophilia)
06/2014 - 06/2011
2Carotid Artery Diseases
03/2005 - 06/2004
1Hypercholesterolemia
02/2024
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2024
1COVID-19
12/2022
1Polyps
01/2022
1Parasitemia
01/2022
1Multiple Myeloma
01/2022
1Severe Acute Respiratory Syndrome
01/2022
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2021
1Purpura
12/2021

Drug/Important Bio-Agent (IBA)

13ThrombinFDA Link
02/2024 - 01/2018
10Biomarkers (Surrogate Marker)IBA
01/2020 - 06/2004
8P-SelectinIBA
01/2022 - 06/2011
7Aryldialkylphosphatase (Paraoxonase)IBA
08/2008 - 06/2004
6von Willebrand FactorIBA
01/2022 - 09/2013
5EnzymesIBA
12/2021 - 06/2004
4AnticoagulantsIBA
01/2022 - 05/2015
4IronIBA
04/2006 - 08/2003
3Thromboplastin (Tissue Factor)IBA
12/2023 - 12/2021
3IntegrinsIBA
10/2022 - 03/2015
3FibrinolysinFDA Link
01/2022 - 03/2014
3CollagenIBA
01/2022 - 01/2012
3C-Reactive ProteinIBA
01/2021 - 03/2005
3HDL CholesterolIBA
02/2016 - 03/2005
3Adenosine Diphosphate (ADP)IBA
03/2015 - 09/2012
3AntibodiesIBA
03/2014 - 12/2004
3HDL LipoproteinsIBA
06/2006 - 06/2004
3oxidized low density lipoproteinIBA
03/2005 - 06/2004
2thiamine triphosphorate (TTP)IBA
02/2024 - 12/2021
2Indicators and Reagents (Reagents)IBA
02/2024 - 02/2016
2Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2022 - 03/2014
2FibrinIBA
01/2022 - 01/2021
2AntigensIBA
01/2022 - 01/2020
2Inosine Triphosphate (ITP)IBA
12/2021 - 03/2014
2LigandsIBA
01/2021 - 02/2016
2fibrin fragment D (D-dimer)IBA
01/2021 - 04/2005
2SelectinsIBA
01/2017 - 09/2013
2Interleukin-6 (Interleukin 6)IBA
02/2016 - 04/2008
2ChemokinesIBA
07/2014 - 01/2014
2Glycoproteins (Glycoprotein)IBA
06/2014 - 03/2014
2Proteins (Proteins, Gene)FDA Link
01/2014 - 01/2014
2Fibrinogen (Factor I)FDA Link
01/2013 - 04/2008
2Antiphospholipid AntibodiesIBA
11/2009 - 12/2004
2Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
11/2009 - 12/2004
2Transferrin (beta 2 Transferrin)IBA
04/2006 - 08/2005
2Ferritins (Ferritin)IBA
04/2006 - 08/2005
2Estrogen Receptor alphaIBA
12/2005 - 11/2005
2factor V LeidenIBA
04/2005 - 07/2002
1Contraceptive Agents (Contraceptives)IBA
02/2024
1CoagulantsIBA
11/2023
1ThrombomodulinIBA
10/2023
1Blood Coagulation Factors (Coagulation Factor)IBA
01/2023
1Adenosine Triphosphate (ATP)IBA
12/2022
1PAR-1 ReceptorIBA
12/2022
1Factor XII (Hageman Factor)IBA
01/2022
1Protein CIBA
01/2022
1Ellagic AcidIBA
01/2022
1KaolinIBA
01/2022
1Kallikreins (Kallikrein)IBA
01/2022
1VaccinesIBA
01/2022
1PolyphosphatesIBA
01/2022
1APTIBA
01/2022
1Heparin (Liquaemin)FDA LinkGeneric
12/2021
1COVID-19 VaccinesIBA
12/2021
1platelet membrane glycoprotein VIIBA
01/2021
1Peptides (Polypeptides)IBA
01/2021
1Factor XIIIaIBA
01/2021

Therapy/Procedure

3Critical Care (Surgical Intensive Care)
12/2022 - 09/2017
2Therapeutics
01/2022 - 01/2018
2Central Venous Catheters
04/2005 - 07/2002
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2005 - 07/2002